Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan

American Heart Journal

Volumn 124, Issue 4, 1992, Pages 1017-1025

  Rector, Thomas S ^a   Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIMOBENDAN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ATTITUDE TO HEALTH; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMAN; MALE; MIDDLE AGE; OUTCOME ASSESSMENT (HEALTH CARE); PYRIDAZINES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; VASODILATOR AGENTS;

EID: 0026699989     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(92)90986-6     Document Type: Article

References (20)

1. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure
2. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy
3. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure
4. A placebo-controlled trial of captopril in refractory chronic congestive heart failure
5. Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study
6. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure
7. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure
8. Analysis of quality of life data from a randomized, placebo controlled heart-failure trial
9. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study
10. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure
11. Exercise capacity and quality of life in the treatment of heart failure
12. Assessment of the quality of life of patients with heart failure: a randomized, controlled drug trial
13. Some methodological problems in analyzing quality of life data in severe congestive heart failure patients
14. Patients self-assessment of their congestive heart failure: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire
15. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: results of a multicenter trial
16. Factor analysis
17. Reliability and validity assessment
18. Coefficient alpha and the internal structure of tests
19. Development and testing of a new measure of health status for clinical trials in heart failure
20. Effects of enoximone on quality of life